Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Bridgewater, New Jersey 08807


Purpose:

The primary objective of this study is to compare the percentage of subjects who reach the target HbA1c level (< or = 7.0% at endpoint) and do not experience symptomatic nocturnal hypoglycemia during treatment with insulin glargine or NPH human insulin.


Criteria:

Inclusion Criteria: - Insulin naïve subjects with type 2 diabetes treated with oral hypoglycemic agents - Body mass index between 26 and 40 kg/m2 - HbA1c between 7.5% and 10.0% - Fasting plasma glucose >7.8 mmol/L and fasting C-peptide > or =0.25 nmol/L


NCT ID:

NCT00653341


Primary Contact:

Study Director
Public Registry ICD
Sanofi-Aventis


Backup Contact:

N/A


Location Contact:

Bridgewater, New Jersey 08807
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.